±â»ç (Àüü 175°Ç) Á¦¸ñº¸±âÁ¦¸ñ+³»¿ë
[Àλç] µ¿±¹Á¦¾à ÀÓ¿ø Àλç
µ¿±¹Á¦¾àÀº 1¿ù 2ÀÏ ½Ã¹«½Ä¿¡¼­ ÃÑ 3¸íÀÇ ÀÓ¿ø Àλ縦 ¹ßÇ¥ÇÏ¿´´Ù.¡ß½ÂÁø Àü¹«ÀÌ»ç¡â Àü¼¼ÀÏ Àü¹«ÀÌ»ç(º¸)¡â È«¼ø°­¡ß½ÅÀÓ ¿¬±¸°³¹ßºÎ¡â ÀÌÈñÀÚ(ÀÌ»ç)
¸ÞµðÄ®·³   2015-01-07
[ÇмúÇà»ç] Lipid Management for diabetic patients
Áö³­ 2013³â 11¿ù ¹ßÇ¥µÈ ACC/AHA °¡À̵å¶óÀο¡¼­´Â ´ÙÀ½ÀÇ 4°³ ȯÀÚ±º¿¡°Ô statin Ä¡·á¸¦ ±ÇÇÏ°í ÀÖ´Ù. ù°, Class II-IV¿¡ ÇØ´çÇÏ´Â ½ÉºÎÀüÀ» µ¿¹ÝÇÏÁö ¾ÊÀ¸¸ç Åõ¼®Ä¡·á°¡ ÇÊ¿äÄ¡ ¾ÊÀº Á׻󵿸ưæÈ­¼º½ÉÇ÷°üÁúȯ(atherosclero
¸ÞµðÄ®·³   2015-01-07
[ÇмúÇà»ç] Recent Advances in Platelet Aggregation Inhibitors
Ç÷¼ÒÆÇ Çü¼º ¹× ÀÀ°í °úÁ¤¿¡¼­´Â Ç÷¼ÒÆÇ È°¼ºÈ­¿Í ÇÔ²² Æ®·Òºó(thrombin)ÀÇ ÀÛ¿ëÀ¸·Î ÁöÇ÷ÀÌ ÀÌ·ç¾îÁö¸é¼­ Ç÷±«(clot)°¡ Çü¼ºµÇ±â ¶§¹®¿¡ ³úÁ¹ÁßÀ» ºñ·ÔÇÑ ½É³úÇ÷°üÁúȯÀÇ Ä¡·á¿Í ¿¹¹æ¿¡´Â ÁÖ·Î ÀÌ ´Ü°è¸¦ Â÷´ÜÇÏ´Â ¾àÁ¦µéÀÌ ÁÖ·Î »ç¿ëµÈ´Ù. ƯÈ÷ P2Y
¸ÞµðÄ®·³   2015-01-07
[ÇмúÇà»ç] HTN Management: FOCUS study
Ç÷¾Ð ÃøÁ¤ÀÇ ±â¿ø ¹× Áß½ÉÇ÷¾ÐÀÇ Á߿伺¡ß Ç÷¾ÐÀÇ ÀÓ»óÀû ÀÇ¹Ì : ÀϹÝÀûÀ¸·Î »ó¿Ï¿¡¼­ ÃøÁ¤ÇÑ Ç÷¾ÐÀ» ±Ù°Å·Î °íÇ÷¾Ð Ä¡·á¸¦ ÇÏ¸é µÈ´Ù°í »ý°¢ÇÏÁö¸¸, ´Ü¼øÈ÷ »ó¿Ï¿¡¼­ ÃøÁ¤ÇÑ Ç÷¾Ð¸¸ ±âÁØÀ¸·Î ÇÏ´Â °Íº¸´Ù Áß½ÉÇ÷¾Ð, pressure wave form¿¡¼­ ÆÄ»ýÇÏ
¸ÞµðÄ®·³   2015-01-06
[ÇмúÇà»ç] ´ëÇѾȰúÇÐȸ Çмú´ëȸ Luncheon symposium
Dr. DAVID DIAZ VALLE / Hospital Clinico San Universitario Carlos(½ºÆäÀθ¶µå¸®µå) ¿À´Ã °­¿¬¿¡¼­´Â ù°, ¾È±¸ Ç¥¸é¿¡ Á¡ÀûÇÏ´Â º¸Á¸Á¦°¡ ÇÔÀ¯µÈ Á¡¾ÈÁ¦ »ç¿ëÀÇ Á߿伺°ú µÑ°, ´«²¨Ç® Ä¡·á¿¡ ´ëÇØ »ìÆ캸°Ú
¸ÞµðÄ®·³   2015-01-05
[Àλç] ±¹¹Î°Ç°­º¸Çè°ø´Ü Àλç¹ß·É ½Ç½Ã
º»ºÎÀå Àüº¸, 1±Þ ½ÂÁø ¹× Àüº¸, »óÀ§Á÷(1±Þ) Àüº¸, 1±Þ ±¹³»Çмú¿¬¼ö ÆÄ°ß, 2±Þ ½ÂÁø ¹× Àüº¸, »óÀ§Á÷(2±Þ) Àüº¸º»ºÎÀå Àüº¸¡â±âȹÁ¶Á¤½ÇÀå ÁøÁ¾¿À ¡âÀηÂÁö¿ø½ÇÀå ÀüÁ¾°© ¡âÁ¤º¸°ü¸®½ÇÀå ¼Û¼±¿± ¡â´ë±¸Áö¿ªº»ºÎÀå ÀÌÅÂÇü ¡â°æÀÎÁö¿ªº»ºÎÀå ÀÌÀÍÈñ (ÀÌ»ó
¸ÞµðÄ®·³   2014-12-30
[ÇмúÇà»ç] °üÀý¿° Ä¡·áÀÇ ÃÖ½ÅÁö°ß Àü¹®°¡Æ÷·³
ÅðÇ༺ ¿äÃߺ¯Çü ±³Á¤¿¡¼­ Àü¹æ¼ö¼úÀÇ ¿ªÇÒÅðÇ༺ ¿äÃߺ¯ÇüÀÇ ¼ö¼úÄ¡·á´Â ´ë°³ ALIF(anterior lumbar interbody fusion)¿Í ÈĹæôÃ߰泪»ç¸ø°íÁ¤¼ú(posterior pedicle screw fixation)À» ÅëÇØ ÀÌ·ç¾îÁø´Ù. ÅðÇà
¸ÞµðÄ®·³   2014-12-03
[ÇмúÇà»ç] An Effective Combination Therapy for Hypertension & Dyslipidemia
´ÙÁß ½ÉÇ÷°ü À§Çè °ü¸®¿Í ÀÓ»óÀû ÀÇÀÇ2008³â Á¶»ç¿¡ ÀÇÇÏ¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀº Àü¼¼°èÀûÀ¸·Î 1,730¸¸·Ê¿¡ À̸£¸ç Àüü »ç¸ÁÀÇ 30%¸¦ Â÷ÁöÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ƯÈ÷ °íÇ÷¾ÐÀ¸·Î ÀÎÇÑ »ç¸ÁÀº 940¸¸ ·Ê·Î Àüü »ç¸ÁÀÇ 16.5%¸¦ Â÷ÁöÇϴµ¥
¸ÞµðÄ®·³   2014-12-03
[Çмú/ÇÐȸ] °æÈñ´ëÇб³º´¿ø À念¿î ±³¼ö, ´ëÇѼÒÈ­±âÇÐȸ ȸÀå ¼±ÀÓ
°æÈñ´ëÇб³º´¿ø(º´¿øÀå ÀÓ¿µÁø) ¼ÒÈ­±â³»°ú À念¿î ±³¼ö°¡ 10¿ù 24ÀÏ(±Ý), ¼Ò°øµ¿ ·Ôµ¥È£ÅÚ¿¡¼­ ¿­¸° ´ëÇѼÒÈ­±âÇÐȸ Á¦2Â÷ ÆòÀÇ¿øȸ¿¡¼­ ȸÀåÀ¸·Î ¼±ÀӵƴÙ. ÀÓ±â´Â 1³âÀÌ´Ù.À念¿î ±³¼ö´Â ¡®Ç︮ÄÚ¹ÚÅÍ °¨¿°°ú °ü·ÃµÈ À§Àå°üÁúȯ ºÐ¾ß ±ÇÀ§ÀÚ¡¯·Î ³Î¸® ¾Ë·ÁÁ®
¸ÞµðÄ®·³   2014-10-28
[ÇмúÇà»ç] Recent Advances in Platelet Aggregation Inhibitors
±Þ¼º ³úÇãÇ÷ ȯÀÚ¿¡°Ô ÀûÇÕÇÑ Ç×Ç÷¼ÒÆÇ ¿ä¹ýÇ÷¼ÒÆÇ È°¼ºÈ­¿Í ÀÀÁýÀº Ç÷Àü»ý¼ºÀÇ ±âº»ÀÌ µÇ´Â °úÁ¤ÀÌ´Ù. ¿©·¯ °¡Áö º¹ÀâÇÑ ´Ü°è¸¦ °ÅÄ¡Áö¸¸, ³»ÇǼ¼Æ÷ ¼Õ»ó¿¡ µû¸¥ Ç÷¼ÒÆÇ È°¼ºÈ­¿Í Ç÷Àü »ý¼ºÀº Ç÷¼ÒÆÇ ÀÀÁýÀ» ÀÌ·ç´Â ±âÃÊ·Î, ADP, Thrombin, TxA2ÀÇ
¸ÞµðÄ®·³   2014-10-14
[ÇмúÇà»ç] Recent Advances in Platelet Aggregation Inhibitors
A Feasible Combination for Patients with Acute Cerebral Ischemia : Role of Ticlopidine+Ginkgo for the prevention of Stroke Ç÷¼ÒÆÇ ÀÀÁý ¹× Ç×Ç÷¼ÒÆÇ Á¦Á¦Ç÷
¸ÞµðÄ®·³   2014-10-14
[ÇмúÇà»ç] °üÀý¿° Ä¡·áÀÇ ÃÖ½ÅÁö°ß Àü¹®°¡ Æ÷·³
°üÀý¿°ÀÇ ¼ö¼úÀû Ä¡·á¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß °üÀý¿°ÀÇ ¼ö¼úÀû Ä¡·á¿¡¼­ Àüü °üÀý¼ºÇü¼ú(total arthroplasty)°ú ÇÔ²² °æ°ñ ±ÙÀ§ºÎÀýÁ¦¼ú(proximal tibia osteotomy, PTO)ÀÇ ¿ªÇÒ°ú Çʿ伺¿¡ ´ëÇØ 2014³â ¹Ì±¹Á¤Çü¿Ü°úÇÐȸ(AAO
¸ÞµðÄ®·³   2014-10-14
[ÇмúÇà»ç] Comprehensive management for diabetic patients
´ç´¢º´ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®¿¡ ´ëÇÑ ÃÖ½ÅÁö°ß Dyslipidemia Management in Diabetes´ç´¢º´ ȯÀÚÀÇ ÁÖ¿ä »ç¸Á¿øÀÎÀ» »ìÆ캸¸é °ü»óµ¿¸Æ½ÉÁúȯ ¹× ±âŸ ½ÉÀåÁúȯ, ³úÁ¹Áß µî ½ÉÇ÷°üÁúȯ(CVD)ÀÌ °ÅÀÇ 60% ÀÌ»óÀ» Â÷ÁöÇÏ°í ÀÖ¾î,
¸ÞµðÄ®·³   2014-10-14
[ÇмúÇà»ç] NSAIDsÀÇ À¯È¿¼º°ú ¾ÈÀü¼º Effectiveness & safety of NSAIDs
¸¸¼º ½ÅÁúȯ(CKD)À» °¡Áø ³»°ú ȯÀÚ¿¡¼­ NSAID »ç¿ë ½Ã ÁÖÀÇÁ¡½ÅÀåÁúȯ ¿µ¿ª¿¡¼­ ¸¸¼º ½ÅºÎÀü(chronic renal failure, CRF)À̳ª ±Þ¼º ½ÅºÎÀü(acute renal failure, ARF)°ú °°Àº ¿ë¾îº¸´Ù´Â ±Þ¼º ½ÅÀå¼Õ»ó(acut
¸ÞµðÄ®·³   2014-10-13
[Topic] ¹Ì¼¼¾ËºÎ¹Î´¢
»ç±¸Ã¼(glomerulus)´Â½ÅÀåÀDZ⺻±¸Á¶¹°·ÎÇϳªÀǽÅÀå¿¡100-150¸¸°³°¡µé¾îÀÖ´Ù. ½ÅÀåÀº Á¤»óÀûÀ¸·Î ÇÏ·ç 180¸®ÅÍ¿¡ ´ÞÇÏ´Â ¼öºÐ°ú ´õºÒ¾î ´Ü¹éÁú µîÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¹°ÁúÀ» ¿©°úÇÏ°í ÀçÈí¼öÇÏ¿© ½ÅüÀÇ Ç×»ó¼º(homeostasis)À» À¯ÁöÇϵµ·Ï ÇÑ´Ù.
½Å¼ºÁØ ±³¼ö   2014-10-13
[ÇмúÇà»ç] Endocrinology Round Table Meeting
¸ÞÆ®Æ÷¸£¹ÎÀº À¯·´¿¡¼­ 1957³âºÎÅÍ ½ÃÀÛÇØ 50³â ÀÌ»ó Àå±â°£ »ç¿ëµÇ¾úÁö¸¸, ¾ÆÁ÷±îÁöµµ °ü·Ã ¿¬±¸°¡ È°¹ßÇÏ°Ô ÁøÇàµÇ°í ÀÖ´Ù. ÇöÀç ÀÓ»óÁø·á¿¡¼­ ¸ÞÆ®Æ÷¸£¹ÎÀÇ »ç¿ë °íÇ÷´çÁõÀÌ ½ÉÇÑ 2Çü ´ç´¢º´ ½Åȯ 47¸íÀ» ´ë»óÀ¸·Î 2ÁÖ°£ ÁýÁßÀûÀÎ Àν¶¸°(insulin)
¸ÞµðÄ®·³   2014-09-17
[Àλç] ¼­¿ï´ë ¹Ú±âÈ£ ±³¼ö, ¾È°ú ±¹Á¦ÇмúÁö ºÎÆíÁýÀÎ À§ÃË
¼­¿ï´ëÇб³º´¿ø ¾È°ú ¹Ú±âÈ£ ±³¼ö°¡ ¼¼°èÀû ±ÇÀ§ÀÇ ¾È°ú ºÐ¾ß ±¹Á¦ÇмúÁö(British Journal of Ophthalmology)ÀÇ ºÎÆíÁýÀÎ(Section Editor)¿¡ À§Ã˵ƴÙ. Çѱ¹ ¾È°ú ÀÇ»ç·Î´Â óÀ½ÀÌ´Ù.¹Ú ±³¼ö´Â ¾ÕÀ¸·Î ÇмúÁö¿¡ Åõ°íµÇ´Â ³í¹®
¸ÞµðÄ®·³   2014-09-17
[ÇмúÇà»ç] Recent Advances in Platelet Aggregation Inhibitors
Ç÷¼ÒÆÇ ÀÀÁý°ú À̸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¾à¹°Ç÷¼ÒÆÇ¿¡ ÀÇÇÑ Ç÷¾×ÀÀ°í¿Í °ü·ÃÇØ Ç÷¼ÒÆÇ ³»¡¤¿ÜºÎ¸¦ Ç¥ÀûÀ¸·Î ÀÛ¿ëÇÏ´Â ¾à¹°À» Ç×Ç÷¼ÒÆÇ Á¦Á¦(antiplatelet agent)¶ó°í ÇÑ´Ù. ´ëÇ¥ÀûÀÎ Ç×Ç÷¼ÒÆÇÁ¦ ¾Æ½ºÇǸ°(Aspirin)Àº COX(cyclooxygenas
¸ÞµðÄ®·³   2014-08-13
[Diabetes Today] [CASE] Á¦2Çü ´ç´¢º´ÀÇ 3Á¦¿ä¹ý: ¸ÞÆ®Æ÷¹Î + SU + DPP-4 ¾ïÁ¦Á¦ º´ÇÕ¿ä¹ý
Á¦2Çü ´ç´¢º´ ȯÀÚÀÇ ¾à¹°¿ä¹ý¿¡¼­ 3Á¦ º´ÇÕ¿ä¹ýÀÇ È¿°ú¿¡ ´ëÇÏ¿©´Â ¸¹Àº ³í¶õÀÌ ÀÖ¾ú°í, ƯÈ÷ ¿ì¸®³ª¶ó¿¡¼­´Â ÃÖ±Ù¿¡¼­¾ß ÀǷẸÇè ±Þ¿©ÀÇ ´ë»óÀ¸·Î ÀÎÁ¤¹Þ°Ô µÇ¾ú´Ù. 3Á¦¿ä¹ý¿¡ ´ëÇÑ ¿¬±¸µµ ÀÖ¾úÀ¸³ª, ´ëºÎºÐÀº 2Á¦ + Àν¶¸° º´ÇÕ¿ä¹ý¿¡ ºñÇÏ¿© ÀåÁ¡ÀÌ Å©Áö
À̹®±Ô ±³¼ö   2014-08-01
[ÇмúÇà»ç] Endocrinology Round Table Meeting
¸ÞÆ®Æ÷¸£¹ÎÀÇ ´Ù¾çÇÑ ÀÓ»ó È¿°ú¿¡ ´ëÇÑ ¿¬±¸µé´ç´¢º´ ½Åȯ¿¡¼­ °íÇ÷´çÁõÀÌ ½ÉÇÒ ¶§ ÁýÁßÀûÀÎ Àν¶¸°(insulin) Ä¡·á¸¦ ÇÏ´Â °ÍÀÌ Ç÷´ç Á¶Àý¿¡ È¿°úÀûÀÓÀº ÀÌ¹Ì ¿©·¯ ¿¬±¸µéÀ» ÅëÇØ Àß ÀÔÁõµÇ¾ú´Ù. ÀÌ ¿¬±¸µéÀ» ±âÃÊ·Î Çؼ­ ÁßÁõ °íÇ÷´çÁõÀ» º¸ÀÌ´Â 2Çü ´ç´¢
¸ÞµðÄ®·³   2014-07-31
 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 
ÁÖ°£ Àαâ±â»ç
¿©¹é
¿©¹é
½Å¹®»ç¼Ò°³¤ý±â»çÁ¦º¸¤ý±¤°í¾È³»¤ýºÒÆí½Å°í¤ý°³ÀÎÁ¤º¸Ãë±Þ¹æħ¤ýÀ̸ÞÀϹ«´Ü¼öÁý°ÅºÎ¤ýû¼Ò³âº¸È£Á¤Ã¥¤ýȸ»ç À¥¸ÞÀÏ
¼­¿ï½Ã ¿ë»ê±¸ ÇÑ°­´ë·Î 39±æ 34-5, 805È£(ÇÑ°­·Î2°¡, ¸®¹öÆÄÅ©)  |  ´ëÇ¥ÀüÈ­ : 02-749-0322  |  Æѽº : 02-749-0323
(ÁÖ)¸ÞµðÄ®·³  |  µî·Ï¹øÈ£ : ¼­¿ï ¾Æ 02869  |  µî·ÏÀÏ : 2013³â 11¿ù 08ÀÏ  |  ¹ßÇàÀΡ¤ÆíÁýÀÎ : ±èÇö¹Î  |  Ã»¼Ò³âº¸È£Ã¥ÀÓÀÚ : ±èÇö¹Î
±¤°í¹®ÀÇ : TEL. 02-749-0322   FAX. 02-749-0323   E-mail. webmaster@medicolumn.com
Copyright © 2013 ¸ÞµðÄ®·³. All rights reserved.